Neuropathological investigation of the hypometabolic regions on positron emission tomography with [ 18F] fluorodeoxyglucose in patients with dementia with Lewy bodies

Journal of the Neurological Sciences

Volumn 314, Issue 1-2, 2012, Pages 111-119

  Kasanuki, Koji ^a   Iseki, Eizo ^a   Fujishiro, Hiroshige ^a   Yamamoto, Ryoko ^a   Higashi, Shinji ^a,b   Minegishi, Michiko ^a   Togo, Takashi ^c   Katsuse, Omi ^c   Uchikado, Hirotake ^c   Furukawa, Yoshiko ^c   Hino, Hiroaki ^b   Kosaka, Kenji ^b   Sato, Kiyoshi ^a   Arai, Heii ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b Yokohama Houyuu Hospital   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Synuclein; 18F FDG PET; A ; Alzheimer's disease; Dementia with Lewy bodies; Neuropathology; Tau

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; FLUORODEOXYGLUCOSE F 18; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; OCCIPITAL CORTEX; PARIETAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENILE PLAQUE; TEMPORAL CORTEX;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AUTOPSY; BRAIN; CELL COUNT; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODY DISEASE; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEURONS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TAU PROTEINS;

EID: 84857046742     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.10.010     Document Type: Article

References (33)

1. M. Higuchi, M. Tashiro, H. Arai, N. Okamura, S. Hara, and S. Higuchi Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies Exp Neurol 162 2000 247 256
2. S. Minoshima, N.L. Foster, and D.E. Kuhl Posterior cingulate cortex in Alzheimer's disease Lancet 344 1994 895
3. S. Minoshima, B. Giordani, S. Berent, K.A. Frey, N.L. Foster, and D.E. Kuhl Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease Ann Neurol 42 1997 85 94
4. S. Minoshima, N.L. Foster, A.A. Sima, K.A. Frey, R.L. Albin, and D.E. Kuhl Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation Ann Neurol 50 2001 358 365
5. J.V. Haxby, C.L. Grady, E. Koss, B. Horwitz, L. Heston, and M. Schapiro Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in dementia of the Alzheimer type Arch Neurol 47 1990 977 980
6. M.S. Mega, S.S. Chen, P.M. Thompson, R.P. Woods, T.J. Karaca, and A. Tiwari Mapping histology to metabolism: coregistration of stained whole-brain sections to premortem PET in Alzheimer's disease Neuroimage 5 1997 147 153
7. 18F-FDG PET study on normal aging and Alzheimer's disease J Nucl Med 45 2004 382 392
8. K.M. Bradley, V.T. O'Sullivan, N.D. Soper, E.M.F. Nagy, A.D. Smith, and B.J. Shepstone Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease Brain 125 2002 1772 1781
9. K. Herholz, H. Schopphoff, M. Schmidt, R. Mielke, W. Eschner, and K. Sheidhauer Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease J Nucl Med 43 2002 21 26
10. K. Ishii, T. Imamura, M. Sasaki, S. Yamaji, S. Sakamoto, and H. Kitagaki Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease Neurology 51 1998 125 130
11. 18F] fluorodeoxyglucose and neuropsychological testing Exp Neurol 191 2005 S95 S103
12. T. Imamura, K. Ishii, N. Hirono, M. Hashimoto, S. Tanimukai, and H. Kazuai Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB) Neuroreport 10 1999 1903 1907
13. I.G. McKeith, D.W. Dickson, J. Lowe, M. Emre, J.T. O'Brien, and H. Feldman Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium Neurology 65 2005 1863 1872
14. 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias J Nucl Med 49 2008 390 398
15. R.L. Albin, S. Minoshima, C.J. D'Amato, K.A. Frey, D.A. Kuhl, and A.A.F. Sima Fluoro-deoyglucose positron emission tomography in diffuse Lewy body disease Neurology 47 1996 462 468
16. 18F-FDG PET normative database of Japanese healthy elderly subjects and its application to demented and mild cognitive impairment patients Int J Geriatr Psychiatry 25 2010 352 361
17. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol (Berl) 82 1991 239 259
18. S.S. Mirra, A. Heyman, D. McKeel, M.D. Sumi, B.J. Crain, and L.M. Brownlee The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 41 1991 479 486
19. Y. Saito, A. Kawashima, N.N. Ruberu, H. Fujiwara, S. Koyama, and M. Sawabe Accumulation of phosphorylated alpha-syunuclein in aging human brain J Neuropathol Exp Neurol 62 2003 644 654
20. M. Pikkarainen, T. Kauppinen, and I. Alafuzoff Hyperphosphorylated tau in the occipital cortex in aged nondemented subjects J Neuropathol Exp Neurol 68 2009 653 660
21. I.G. McKeith, D. Galasko, K. Kosaka, E.K. Perry, D.W. Dickson, and L.A. Hansen Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Neurology 47 1996 1113 1124
22. D. Aarsland, R. Perry, A. Brown, J.P. Larsen, and C. Ballard Neuropathology of dementia in Parkinson's disease: a prospective, community-based study Ann Neurol 58 2005 773 776
23. H. Fujishiro, T.J. Ferman, B.F. Boeve, G.E. Smith, N.R. Graff-Radford, and R.J. Uitti Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases J Neuropathol Exp Neurol 67 2008 649 656
24. T. Lashley, J.L. Holton, E. Gray, K. Kirkham, S. O'Sullivan, and A. Hilbig Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients Acta Neuropathol (Berl) 115 2008 417 425
25. K. Obi, H. Akiyama, H. Kondo, Y. Shimomura, M. Hasegawa, and T. Iwatsubo Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy Bodies Exp Neurol 210 2008 409 420
26. G. Chételat, N. Villain, B. Desgranges, F. Eustache, and J.C. Baron Posterior cingulate hypometabolism in early Alzheimer's disease: what is the contribution local atrophy versus disconnection? Brain 132 2009 1 2
27. N. Villain, B. Desgranges, F. Viader, V. de la Sayette, F. Mézenge, and B. Landeau Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease J Neurosci 24 2008 6174 6181
28. A.C. McKee, R. Au, H.J. Cabral, N.W. Kowall, S. Seshadri, and C.K. Kubilus Visual association pathology in preclinical Alzheimer disease J Neuropathol Exp Neurol 65 2006 621 630
29. W.R. Markesbery, G.A. Jicha, H. Liu, and F.A. Schmitt Lewy body pathology in normal elderly subjects J Neuropathol Exp Neurol 68 2009 816 822
30. T. Mori, M. Ikeda, R. Fukuhara, P.J. Nestor, and H. Tanabe Correlation of visual hallucination with occipital rCBF changes by donepezil in DLB Neurology 66 2006 935 937
31. E. Iseki, W. Marui, K. Kosaka, H. Akiyama, K. Ueda, and T. Iwatsubo Degenerative terminals of the perforant pathway are human α-synuclein- immunoreactive in the hippocampus of patients with diffuse Lewy body disease Neurosci Lett 258 1998 81 84
32. O. Katsuse, E. Iseki, W. Marui, and K. Kosaka Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies J Neurosci 211 2003 29 35
33. R. Yamamoto, E. Iseki, N. Murayama, M. Minegishi, W. Marui, and T. Togo Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies J Neurol Sci 246 2006 95 101